Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-28 Simpson Curran SVP, Product Development & CTO Sale −18,000 $50.00 $900K 39,500
2019-05-28 Simpson Curran SVP, Product Development & CTO Exercise or conversion · Stock Option (Right to Buy) −18,000 25,219
2019-05-20 Mills Kenneth T. President and CEO Exercise or conversion +15,000 $0.85 $13K 261,000
2019-05-20 Mills Kenneth T. President and CEO Sale −4,141 $42.08 $174K 256,859
2019-05-20 Mills Kenneth T. President and CEO Sale −10,559 $43.32 $457K 246,300
2019-05-20 Mills Kenneth T. President and CEO Sale −300 $43.99 $13K 246,000
2019-05-20 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 129,670
2019-04-22 Mills Kenneth T. President and CEO Exercise or conversion +15,000 $0.85 $13K 261,000
2019-04-22 Mills Kenneth T. President and CEO Sale −3,401 $49.29 $168K 257,599
2019-04-22 Mills Kenneth T. President and CEO Sale −6,929 $50.31 $349K 250,670
2019-04-22 Mills Kenneth T. President and CEO Sale −3,270 $51.07 $167K 247,400
2019-04-22 Mills Kenneth T. President and CEO Sale −1,300 $52.33 $68K 246,100
2019-04-22 Mills Kenneth T. President and CEO Sale −100 $53.05 $5K 246,000
2019-04-22 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 144,670
2019-04-18 Christmas Patrick J. SVP, General Counsel Exercise or conversion +3,541 $12.10 $43K 6,547
2019-04-18 Christmas Patrick J. SVP, General Counsel Exercise or conversion +1,459 $19.50 $28K 8,006
2019-04-18 Christmas Patrick J. SVP, General Counsel Sale −2,900 $52.55 $152K 5,106
2019-04-18 Christmas Patrick J. SVP, General Counsel Sale −1,115 $53.67 $60K 3,991
2019-04-18 Christmas Patrick J. SVP, General Counsel Sale −885 $54.66 $48K 3,106
2019-04-18 Christmas Patrick J. SVP, General Counsel Sale −100 $55.50 $6K 3,006

Page 28 of 43 · 852 trades